COTY reported quarterly results Wednesday, and the immediate read from positioning data is that the short-covering trend that defined July has stalled — and fractionally reversed.
Yesterday's earnings preview noted shorts in steady retreat, with SI % of free float falling from roughly 7.1% in early July to around 5.1%. That decline has now paused. Short interest ticked up 2.1% on the day and 2.1% on the week, landing at 5.24% of free float — still well below the July peak, but no longer falling. The pattern in the history data is clear: covering was aggressive through July and into early August, compressing the position from nearly 63 million shares to a trough near 44.7 million. The last few sessions have seen that number edge back up to 45.8 million. Whether this is fresh shorting into the print or simply noise around the event is the question worth watching.
Borrow conditions remain entirely benign, which argues against any squeeze reading. Cost to borrow is 0.43% — low by any standard and down roughly 5% on the week. Availability is 365% of short interest, meaning there are roughly 249 million shares still available to lend against a position of 45.8 million shorted. That is a loose lending market. Options positioning tells the same relaxed story: the put/call ratio is 0.29, essentially in line with its 20-day average of 0.30, and well off its 52-week high of 0.69. There is no defensive hedging spike visible in the options market around this earnings event. The previous article's characterisation of call dominance persists.
The Street remains in wait-and-see mode. The consensus is a hold, with 14 analysts sitting on the fence and no recent upgrades in the published data — the most recent moves, from Citigroup and TD Cowen back in May, both raised targets modestly (to $2.80 and $2.90 respectively) while keeping neutral ratings. Those targets sit close to the current price of $2.74. RBC's outlying $8.00 Outperform target is a significant outlier relative to where the stock trades and where the rest of the Street clusters. The bull case centres on prestige segment growth and a new CEO framework; the bear case points to fragmentation in fragrance and mass cosmetics and ongoing pressure from influencer-led brands. A recent note flagged better-than-expected quarterly results, which squares with the 5% one-month price gain — though the stock is still down nearly 3% on the week. EV/EBITDA is running at 8.2x, with a price-to-book below 0.71. The EPS surprise factor score ranks in the 100th percentile, meaning the company has been beating estimates consistently, while the 90-day EPS momentum score of 94 suggests forward estimates are rising. The 30-day reading of 22 is much weaker, pointing to some near-term revision softness. Factor scores on the short side are subdued: the short score rank of 15 suggests limited bearish conviction relative to the broader universe.
The institutional picture is dominated by JAB Holdings at 51% of shares — a controlling stake that has not changed. BlackRock added 22.5 million shares through July, bringing its position to 8.2% of the company. That is a notable addition from a passive-leaning manager and reflects index-weight mechanics rather than an active bet, but the size of the move is worth registering. Vanguard and State Street also added modestly in the same period. The insider data is stale (last trade was April 3), so no read-through from that channel.
With the print now in, the setup to watch is whether the short position continues to drift higher from its August trough or resumes its earlier decline — that direction will say something about how the market has digested the results relative to already-cautious expectations.
See the live data behind this article on ORTEX.
Open COTY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
